Afatinib N-oxide is an active pharmaceutical ingredient metabolite, specifically an oxidized derivative of afatinib. It is a quinazoline-based compound with an N-oxide functional group, characterized by aromatic rings, ether linkages, and halogen substituents.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2413212-11-8
Afatinib impurity 12
Afatinib impurity reference standard
Afatinib Impurity I
pharmaceutical reference standard
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
active pharmaceutical ingredient metabolite
1'-hydroxymidazolam
active pharmaceutical ingredient metabolite
2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acid
active pharmaceutical ingredient metabolite
Losartan carboxylic acid
active pharmaceutical ingredient metabolite
Isavuconazole
antifungal active pharmaceutical ingredient
Isoconazole nitrate
antifungal active pharmaceutical ingredient
(E)-4-[[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]amino]-N,N-dimethyl-4-oxobut-2-en-1-amine oxide
IABSYXLQTGEUIV-CWDCEQMOSA-N
C[N+](C)(C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4)[O-]